CABALETTA BIO INC's ticker is CABA and the CUSIP is 12674W109. A total of 55 filers reported holding CABALETTA BIO INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $29,954,604 | +34.8% | 1,968,108 | +14.3% | 0.00% | 0.0% |
Q2 2023 | $22,224,721 | +141.3% | 1,721,512 | +54.5% | 0.00% | – |
Q1 2023 | $9,212,308 | +7.2% | 1,113,943 | +19.9% | 0.00% | – |
Q4 2022 | $8,594,998 | +934.3% | 929,189 | -27.3% | 0.00% | – |
Q3 2022 | $831,000 | -25.5% | 1,278,551 | +21.6% | 0.00% | – |
Q2 2022 | $1,115,000 | -47.8% | 1,051,838 | 0.0% | 0.00% | – |
Q1 2022 | $2,135,000 | -37.7% | 1,051,838 | +16.3% | 0.00% | – |
Q4 2021 | $3,428,000 | -61.4% | 904,492 | +23.8% | 0.00% | – |
Q3 2021 | $8,887,000 | +41.5% | 730,781 | +0.1% | 0.00% | – |
Q2 2021 | $6,280,000 | -18.5% | 730,199 | +5.2% | 0.00% | – |
Q1 2021 | $7,701,000 | -5.8% | 693,885 | +6.0% | 0.00% | – |
Q4 2020 | $8,173,000 | +31.5% | 654,903 | +14.2% | 0.00% | – |
Q3 2020 | $6,215,000 | +116.9% | 573,330 | +122.8% | 0.00% | – |
Q2 2020 | $2,866,000 | +29.0% | 257,277 | -15.5% | 0.00% | – |
Q1 2020 | $2,222,000 | -47.7% | 304,393 | +0.1% | 0.00% | – |
Q4 2019 | $4,247,000 | – | 303,990 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
5AM Venture Management, LLC | 2,064,263 | $4,190,000 | 0.92% |
Kynam Capital Management, LP | 616,125 | $1,251,000 | 0.41% |
Ikarian Capital, LLC | 1,020,070 | $2,070,000 | 0.27% |
Cormorant Asset Management, LP | 1,154,424 | $2,343,000 | 0.18% |
Ikarian Capital, LLC | 449,000 | $912,000 | 0.12% |
HARBOR CAPITAL ADVISORS, INC. | 119,315 | $242,000 | 0.11% |
Boxer Capital, LLC | 540,000 | $1,096,000 | 0.06% |
SAMLYN CAPITAL, LLC | 1,768,083 | $3,589,000 | 0.05% |
Redmile Group, LLC | 696,377 | $1,414,000 | 0.04% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 464,252 | $942,000 | 0.02% |